How to slow the progression of chronic renal insufficiency;Comment ralentir l'évolution de l'insuffisance rénale chronique

Revue du Praticien

Volumn 51, Issue 4, 2001, Pages 378-384

  Rossert, J ^a   Ronco, P ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; COMORBIDITY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICROALBUMINURIA; PATIENT CARE; PROTEIN CONTENT; PROTEINURIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; DIET; DISEASE PROGRESSION; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; PROTEINURIA;

EID: 0035961379     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Progression de l'insuffisance rénale chronique
2. The renal risks of smoking
3. Effect of age and blood pressure on the relation between smoking and chronic renal failure in primary glomerular nephropathies: A case-control study
4. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
5. Blood pressure control, proteinuria, and the progression of renal disease
6. Effect of intensive blood pressure control on the course of type I diabetic nephropathy
7. Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study
8. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
9. Long-term effects of antihypertensive agents on proteinuria and renal function
10. Angiotensin in progressive renal diseases: Theory and practice
11. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
12. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria
13. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria
14. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
15. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients
16. Use of enalapril to attenuate decline in renal normotensive, normoalbuminuric patients with type 2 diabetes mellitus
17. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
18. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICROHOPE substudy
19. Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial
20. Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure
21. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
22. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
23. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial
24. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
25. Renoprotective therapy: Titration against urinary protein excretion
26. Protein-restricted diets in chronic renal failure: A four year follow-up shows limited indications
27. Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency
28. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis